Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

HIV-Positive People Taking HAART Less Likely to Experience Brain Damage, Study Says

October 10, 2007

HIV-positive people taking highly active antiretroviral therapy are less likely to experience brain damage associated with the virus, according to a study published in the Oct. 9 issue of the journal Neurology, Reuters reports.

Asa Mellgren of Goteborg University in Sweden and colleagues tested the cerebrospinal fluid of 53 HIV-positive men and women before providing them with HAART for one year. Before taking HAART, 21 of the study participants had high levels of the neurofilament light protein, which is believed to be linked with brain damage. After three months of treatment with HAART, almost half of the study participants who initially had high levels of NLP were found to have normal levels. After one year of HAART, only four participants had high levels of NLP, the researchers found.

In addition, of the patients who had normal NLP levels at the outset of the study, all but one had normal levels after one year. According to the researchers, the study also found a way to measure progressive brain damage among people living with HIV/AIDS.

Advertisement
HAART "appears to halt the neurodegenerative process caused by HIV," Mellgren said, adding that the study "confirms that NLP serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART" (Reuters, 10/8).

Online An abstract of the study is available online.

Back to other news for October 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Neurological Complications of AIDS Fact Sheet
More News and Research on Neurological and Neurocognitive Complications

Tools
 

Advertisement